Sfoglia per AUTORE
ATZENI F
Collezione AO Ordine Mauriziano

  

Items : 12

The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry. in Arthritis & rheumatology (Hoboken, N.J.) / Arthritis Rheumatol. 2024 Jul;76(7):1141-1152. doi: 10.1002/art.42845. Epub 2024 May 15.
2024
AO Ordine Mauriziano

Ruscitti P; Masedu F; Vitale A; Caggiano V; Di Cola I; Cipriani P; Valenti M; Mayrink Giardini HA; de Brito Antonelli IP; Dagostin MA; Lopalco G; Iannone F; Maria M; Almaghlouth IA; Asfina KN; Ali HH; Ciccia F; Iacono D; Pantano I; Mauro D; Sfikakis PP; Tektonidou M; Laskari K; Berardicurti O; Dagna L; Tomelleri A; Tufan A; Can Kardas R; Hinojosa-Azaola A; et alii...

2023
AO Ordine Mauriziano

Ruscitti P; Masedu F; Vitale A; Di Cola I; Caggiano V; Di Muzio C; Cipriani P; Valenti M; Berardicurti O; Navarini L; Iacono D; Pantano I; Mauro D; Ciccia F; Rossi S; De Stefano L; Monti S; Bugatti S; Montecucco C; Caso F; Costa L; Prete M; Perosa F; Iagnocco A; Atzeni F; Guggino G; Giardini H; Antonelli IPB; Almaghlouth IA; et alii...

Adult-onset Still's disease with elderly onset: results from a multicentre study. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Sep;40(8):1517-1525. doi: 10.55563/clinexprheumatol/0215kv. Epub 2022 May 4
2022
AO Ordine Mauriziano

Di Cola I; Di Muzio C; Conforti A; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Bugatti S; Montecucco C; Ciccia F; Giacomelli R; Cipriani P; Ruscitti P;

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 Oct 6;61(10):4124-4129. doi: 10.1093/rheumatology/keac027.
2022
AO Ordine Mauriziano

Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; et alii...

Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey. in Frontiers in medicine / Front Med (Lausanne). 2022 May 24;9:833139. doi: 10.3389/fmed.2022.833139. eCollection 2022.
2022
AO Ordine Mauriziano

D'Angelo S; Afeltra A; Atzeni F; Baldissera E; Caminiti M; Ciccia F; D'Agostino MA; Dagna L; Erre GL; Franceschini F; Fusaro E; Giacomelli R; Gremese E; Guggino G; Lomater C; Lubrano E; Padula AA; Pagano Mariano G; Russo R; Sarzi Puttini P; Scarpa R; Selmi C; Tirri E; Ferri S; Iannone F;

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.
2020
AO Ordine Mauriziano

Scagliotti GV; Atzeni F; Di Maio M; Muratori L; Parisi F; Trevisi E; Brizzi MP; La Salvia A;

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. in International journal of rheumatic diseases / Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.
2018
AO Ordine Mauriziano

Favalli EG; Sinigaglia L; Becciolini A; Grosso V; Gorla R; Bazzani C; Atzeni F; Sarzi Puttini PC; Fusaro E; Pellerito R; Caporali R;

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Sep-Oct;35(5):804-809. Epub 2017 Jul 27.
2017
AO Ordine Mauriziano

Manara M; Caporali R; Favalli EG; Grosso V; Atzeni F; Sarzi Puttini P; Gorla R; Bazzani C; Fusaro E; Pellerito R; Rocchetta PA; Sinigaglia L;

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.
2017
AO Ordine Mauriziano

Codullo V; Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G; Caporali R;

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. in Clinical rheumatology / Clin Rheumatol. 2017 Apr;36(4):753-761. doi: 10.1007/s10067-016-3528-y. Epub 2017 Jan 5.
2017
AO Ordine Mauriziano

Monti S; Klersy C; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability. in Clinical rheumatology / Clin Rheumatol. 2016 Nov;35(11):2649-2656. doi: 10.1007/s10067-016-3349-z. Epub 2016 Jul 14.
2016
AO Ordine Mauriziano

Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Caporali R; Codullo V; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G;

2016
AO Ordine Mauriziano

Varisco V; Viganò M; Batticciotto A; Lampertico P; Marchesoni A; Gibertini P; Pellerito R; Rovera G; Caporali R; Todoerti M; Covelli M; Notarnicola A; Atzeni F; Sarzi-Puttini P;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte